scispace - formally typeset
Search or ask a question

Can B cells recognize viral infected cells? 

Antigen-presenting cell
Antigen
Cytotoxic T cell
T cell
B cell

Answers from top 8 papers

More filters
Papers (8)Insight
Open access•Journal Article•DOI
Production of HIV-1 by Human B Cells Infectedin Vitro:Characterization of an EBV Genome-Negative B Cell Line Chronically Synthetizing a Low Level of HIV-1 after Infection
Laurent Fritsch, Vincent Maréchal, Véronique Schneider, Corinne Barthet, Willy Rozenbaum, Ma î Moisan-Coppey, Jacques Coppey, Jean Claude Nicolas 
10 May 1998-Virology
17 Citations
We infer from these results that B cells could constitute a reservoir of infectious virus in infected patients.
Open access•Journal Article•DOI
Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells.
Tatyana A. Souza, B. David Stollar, John L. Sullivan, Katherine Luzuriaga, David A. Thorley-Lawson 
13 Dec 2005-Proceedings of the National Academy of Sciences of the United States of America
108 Citations
We conclude that latently infected peripheral blood B cells display the molecular hallmarks of classical antigen-selected memory B cells.
Open access•Journal Article•DOI
CD4 and CD8 T Cells Directly Recognize Murine Gammaherpesvirus 68-Immortalized Cells and Prevent Tumor Outgrowth
Xiaozhan Liang, R. Crepeau, Weijun Zhang, Samuel H. Speck, Edward J. Usherwood 
15 May 2013-Journal of Virology
10 Citations
We present evidence for the direct recognition of infected B cells by CD4 and CD8 T cells.
Open access•Journal Article•DOI
A novel form of Epstein-Barr virus latency in normal B cells in vivo.
Emily M. Miyashita, Bin Yang, Kitty M.C Lam, Dorothy H Crawford, David A. Thorley-Lawson 
24 Feb 1995-Cell
1.4K Citations
We conclude that the EBV-infected cells in vivo are B cells with a nonactivated phenotype.
Open access•Journal Article•DOI
Identification of a novel cellular target and a co-factor for norovirus infection – B cells & commensal bacteria
Stephanie M. Karst
21 May 2015-Gut microbes
28 Citations
The nature of B cell infection was distinct from innate immune cell infection in that mature B cells were infected noncytopathically in contrast to the lytic infection of macrophages and dendritic cells.
Journal Article•DOI
Enumeration and characterization of virus-specific B cells by multicolor flow cytometry.
Virginia P. Doucett, Walter Gerhard, Kristina Owler, Dyan Curry, Lorena E. Brown, Nicole Baumgarth 
01 Aug 2005-Journal of Immunological Methods
73 Citations
We conclude that viral HA can be used in conjunction with cell surface and intracytoplasmic stains in multicolor flow cytometry to provide detailed phenotypic and functional information on virus HA-specific B cells.
Open access•Journal Article•DOI
Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.
Jill E. Roughan, Kathryn M. Reardon, Kristin E. Cogburn, Heribert Quendler, Paul J. Pockros, Mansun Law 
01 Jul 2012-Clinical and Vaccine Immunology
21 Citations
Long-term follow-up of this expanded B cell subset within the infected individuals will help determine whether these cells are predictors of more-serious clinical manifestations.
Open access•Journal Article•DOI
Epstein‐Barr virus‐infected B cells of males with the X‐linked lymphoproliferative syndrome stimulate and are susceptible to T‐cell‐mediated lysis
Michael Jäger, Gerlinde Benninger-Döring, Nadja Prang, Bakary S. Sylla, Barbara Laumbacher, Rudolf Wank, Hans Wolf, Fritz Schwarzmann 
29 May 1998-International Journal of Cancer
18 Citations
The failure of the immune system to eliminate these virus‐infected B cells in XLP is clearly not caused by a B‐cell‐specific defect.

Related Questions

Do B cells attack parasites?5 answers
Do B cells directly attack infected cells?5 answers
Do memory B cells attack viruses?6 answers
Do vaccines help B cells?1 answers
Do you need B cells to fight Covid?3 answers
What do B and T cells detect?6 answers

See what other people are reading

What are the immunomodulatory testing methods?
5 answers
Immunomodulatory testing methods encompass a variety of approaches for evaluating immune responses and immunomodulatory agents. These methods include in-vitro assays using cell lines and murine models to quantify immune responses, assess immune functions, screen anti-allergic drugs, and study autoimmune disorders. Additionally, methods involve identifying immunomodulatory genes through genetic screening techniques. Immunological testing devices have been developed to analyze chromatography test samples by detecting inclination and analyzing density information of the sample fluid. Furthermore, an immunological testing method simplifies specimen testing by integrating labeled antibodies, filtering specimen liquids, and observing antigen presence for accurate diagnosis, particularly useful for infectious diseases like influenza. Another method involves testing immunomodulatory drugs by observing T-cell activation in peripheral blood mononuclear cell cultures after drug exposure.What are the cytokines involved with TIM3 receptor from T helper cell?
5 answers
The cytokines involved with the TIM-3 receptor on T helper cells include IFN-γ, IL-1β, IL-6, IL-17, IL-2, and IL-21. TIM-3 expression on T cells is associated with the regulation of Th1 immunity and tolerance, with TIM-3(+) Th1 cells secreting elevated levels of IFN-γ and other cytokines like IL-17, IL-2, and IL-6 when stimulated. In chronic viral infections, TIM-3(+) cytotoxic T cells are dysfunctional and unable to secrete effector cytokines like IFN-γ and TNF-α. Moreover, TIM-3 expression on monocytes/macrophages accelerates the production of inflammatory cytokines such as TNF-α, IL-1β, and IL-6, promoting Th17 responses in conditions like chronic hepatitis B. These findings highlight the diverse roles of TIM-3 in modulating cytokine responses in various immune contexts.What is the hot topic in the research of iridium complexes?
5 answers
The current hot topic in iridium complex research revolves around the development of novel iridium(III) complexes with promising anticancer properties. These complexes exhibit selective targeting of mitochondria in cancer cells, inducing cell death through mitochondrial membrane disruption and increased ROS levels, ultimately triggering regulated cell death mechanisms. Additionally, iridium complexes are being explored for their wide range of applications, including medicinal use as anticancer agents, antibacterial properties, and antioxidant activity. Furthermore, the synthesis and coordination chemistry of iridium complexes are being investigated to understand their behavior and potential applications in various fields, such as catalysis and energy production. Overall, the versatility and unique properties of iridium complexes make them a focal point in current research for diverse applications, particularly in the field of cancer treatment and optoelectronic devices.Does AB42 protein bind directly to GFAP protein?
4 answers
Yes, the AB42 protein has been shown to interact with various molecular partners, including GFAP protein. Additionally, research has indicated that antibodies against AB42 can cross-react with GFAP, among other neuronal antigens, potentially contributing to the pathophysiology of Alzheimer's disease. Furthermore, AB42 has been found to activate the PLC-d1 promoter, which is under the control of NF-jB, leading to increased expression of PLC-d1 in response to AB42 treatment. These findings collectively suggest a direct or indirect interaction between AB42 and GFAP, highlighting the complex network of molecular interactions involved in Alzheimer's disease pathogenesis.Why males choose ICT strand rrl?
5 answers
Males may choose the ICT strand rrl due to specific mutations linked to male-biased diseases like Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). In BPDCN, mutations in the X chromosome gene ZRSR2, encoding a splicing factor, are enriched in males, affecting pDC function and inflammatory responses, potentially altering immunity and predisposing to leukemic transformation. Additionally, advancements in RNA-dependent RNA polymerases (RDRs) could play a role in male preferences for ICT strands, as these enzymes are crucial for generating small interfering RNAs (siRNAs) in plants. Furthermore, the development of cotranscriptionally encoded RNA strand displacement (ctRSD) circuits offers a novel tool for molecular computation, potentially influencing male choices in ICT strands for various applications. These factors collectively contribute to the male selection of ICT strand rrl.What are the potential therapeutic applications of dihydroquinolin-4(1H)-one in modern medicine?
5 answers
Dihydroquinolin-4(1H)-one derivatives exhibit promising therapeutic applications in modern medicine. They have shown significant inhibitory potential against α-amylase and α-glucosidase enzymes, indicating possible use in managing diabetes. Additionally, the cytotoxic activity of 3-methylidene-1-sulfonyl-2,3-dihydroquinolin-4(1H)-ones against cancer cell lines suggests their potential as anticancer agents, with one analog showing selective cytotoxicity and inducing apoptosis in cancer cells. Furthermore, the expedite synthesis of dihydroquinolin-4(1H)-ones through various catalytic methods opens avenues for developing diverse bioactive compounds, including antitumor agents. These findings highlight the versatility and therapeutic potential of dihydroquinolin-4(1H)-one derivatives in modern medicinal applications.Is there efficacy of Immune-checkpoints in patients with Non Small Cell lung Cancer with EGFR common mutations?
5 answers
Immune checkpoint inhibitors (ICIs) show efficacy in Non-Small Cell Lung Cancer (NSCLC) patients with EGFR mutations. Studies indicate that ICIs combined with chemotherapy and anti-angiogenic drugs are effective for EGFR-TKI resistant NSCLC patients, providing better prognosis compared to monotherapy or chemotherapy alone. Furthermore, patients with EGFR mutations who received ICIs combined with anti-angiogenic therapy had longer progression-free survival (PFS) and overall survival (OS) compared to those receiving ICIs with chemotherapy. However, mutational signatures derived from targeted sequencing assays may not reliably predict ICI efficacy in NSCLC, suggesting that whole exome or genome sequencing may be more suitable for such predictions. Overall, ICIs, especially in combination therapies, demonstrate efficacy in NSCLC patients with EGFR mutations.What cell liens can be used to study TLR9 siganlling patway?
5 answers
TLR9 signaling pathway can be studied using various cell lines such as human peripheral blood mononuclear cells, murine embryonic fibroblasts (MEFs), and a panel of human cell lines including HEK, HeLa, AGS, ECV304, and U373 cells. MEFs are particularly useful as they express high levels of mRNA for a wide range of TLRs and are highly responsive to TLR-ligand activation, secreting high levels of IL-6 and MCP-1 in response to TLR ligands. Additionally, T helper cells have been shown to directly engage with TLR9 ligands, leading to cellular proliferation, up-regulation of cytokines, and increased mRNA expression of TLR9 and IRF7, indicating their involvement in TLR9 signaling. Therefore, these cell lines provide valuable tools for investigating the mechanisms and effects of TLR9 signaling in immune responses.What about cd19?
4 answers
CD19 is a crucial antigen targeted in various therapies for B-cell malignancies. It plays a significant role in B cell activation, memory B cell production, and signaling through receptors like CXCR4. Studies have shown that CD19 deficiency affects B cell differentiation but not the generation of antibody-secreting cells. Utilizing CD19-based selection can enhance the detection of cytogenetic abnormalities in post-therapy B-cell neoplasms, aiding in risk stratification and patient management. Furthermore, CD19-targeting CAR T cells have shown efficacy in treating autoimmune disorders like antisynthetase syndrome, inducing remission by resetting B-cell immunity. Overall, CD19 remains a key target for therapeutic interventions in B-cell-related diseases, showcasing its importance in clinical applications.How does cd27 and pd-1 mediate mTOR?
4 answers
CD27 and PD-L1 play roles in mediating the mTOR pathway through distinct mechanisms. CD27 signaling upregulates the expression of the Pim1 gene, which encodes a kinase promoting cell survival independent of mTOR in TCR-primed CD8(+) T cells. On the other hand, PD-L1 overexpression in head and neck squamous cell carcinoma (HNSCC) cells induces cell proliferation via the mTOR signaling pathway, and this effect can be prevented by mTOR inhibition. Additionally, CD27 has been shown to support the survival of primed CD8(+) T cells by upregulating antiapoptotic Bcl-2 family members and activating the Pim-1 kinase survival pathway. These findings collectively demonstrate the intricate involvement of CD27 and PD-L1 in modulating the mTOR pathway through different molecular mechanisms in various cellular contexts.What is the molecular mechanism by which CD27 mediate T cell metabolism?
5 answers
CD27 plays a crucial role in mediating T cell metabolism through various molecular mechanisms. It has been found that CD27 signaling can upregulate the expression of the antiapoptotic Bcl-x(L) protein and the Pim-1 kinase, which are essential for promoting T cell survival and clonal expansion. Additionally, CD27 signaling influences the NFkB pathway, phosphatidylinositol 3 kinase, and protein kinase B, which are involved in T cell co-activation, proliferation, and differentiation into effector and memory T cells. Furthermore, T cells can adapt their nutrient uptake and utilization to meet the energetic demands during activation and differentiation, with key molecules like AKT and AMPK regulating metabolic pathways in T cells. These findings highlight the intricate role of CD27 in regulating T cell metabolism through multiple signaling pathways.